Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D48ZBO
|
|||
| Drug Name |
FOR46
|
|||
| Drug Type |
Antibody drug conjugate
|
|||
| Indication | Multiple myeloma [ICD-11: 2A83; ICD-10: C90] | Phase 1 | [1] | |
| Company |
Fortis Therapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Membrane cofactor protein (CD46) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03650491) A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Fortis Therapeutics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.